The following stories appear in full on today's Vidyya Medical News Service Web site.
Around 30% of pesticides marketed in developing countries with an estimated market value of US $900 million annually do not meet internationally accepted quality standards. They are posing a serious threat to human health and the environment, the UN Food and Agriculture Organization (FAO) and the World Health Organization (WHO) warned in a joint statement on Friday.
For more information: FAO/WHO: Amount Of Poor-Quality Pesticides Sold In Developing Countries Alarmingly High
Household insecticide products are typically formulated as dilute and ready-to-use products, as compared to the more concentrated forms typically used by professional and government vector control applicators. As such, they can be easily applied by the general public and are readily available in shops, drugstores, supermarkets and other outlets. Nevertheless, these products contain toxic ingredients and therefore must be handled with care and in accordance with the manufacturer's recommendations for use. It is therefore critical that instructions for safe use are easily comprehensible to consumers of all literacy levels.
For more information: Safe And Effective Use Of Household Insecticide Products: Guide For The Production Of Educational And Training Materials
National Institute of Mental Health (NIMH) researchers report that some children whose symptoms of obsessive-compulsive disorder (OCD) and tic disorders were worsened by a common strep infection have been successfully treated with plasma exchange (PEX) and intravenous immunoglobulin (IVIG). Dr. Susan Swedo and colleagues at the National Institutes of Health reported their findings in the October 2 issue of Lancet.
For more information: Treatments Reduce Strep-Triggered Symptoms Of OCD And Tics In Some Children
In recent years clinical psychopharmacology research has been dominated by the pharmaceutical industry. While industry-sponsored research is critical to new product development, its emphasis is on meeting regulatory and marketing requirements and on obtaining expanded marketing claims for the drug--not on evaluating the effectiveness of the product at the general population level. As a result, industry-sponsored research does not address broad public health needs or the needs of individual practitioners seeking to make good clinical decisions for individual patients. The CATIE trial seeks to provide a different type of information for health practitioners. The trial started in October, 2000.
For more information: The Clinical Antipsychotic Trials Of Intervention Effectiveness Project (CATIE): Research Project To Evaluate The Clinical Effectiveness Of Atypical Antipsychotics In The Treatment Of Schizophrenia And Alzheimer's Disease
Obsessive-compulsive disorder (OCD), one of the anxiety disorders, is a potentially disabling condition that can persist throughout a person's life. The individual who suffers from OCD becomes trapped in a pattern of repetitive thoughts and behaviors that are senseless and distressing but extremely difficult to overcome. OCD occurs in a spectrum from mild to severe, but if severe and left untreated, can destroy a person's capacity to function at work, at school, or even in the home. This extensive brochures, with links to outside areas contains case studies, helpful resources and more.
For more information: Information For Patients: Obsessive-Compulsive Disorder
Today's Vidyya articles are:
As always, we hope you enjoy the issue.